Board of Directors
Ms. White currently serves on the board of directors of Howden Joinery Group PLC (LSE: HWDN), a UK-headquartered FTSE250 multinational building trade supplier with 10,000 employees and over $2 billion in revenue and as a trustee of Wellbeing of Women, a UK charity which invests in medical research and development of specialist clinicians in women’s health. Ms. White recently served as a strategic consultant to Oxford Nanopore Technologies Ltd., a UK biotechnology company that develops and commercializes DNA/RNA sequencing technologies, and its emerging Oxford Nanopore Diagnostics business unit.
Early in the COVID-19 pandemic, Ms. White worked with the UK government to help establish COVID-19 testing facilities across the nation.
Ms. White previously served as Group CEO of Interserve Group (LSE: IRV), a UK-headquartered multinational group of support services and construction companies with 75,000 employees and over $4 billion in revenue, during a challenging period which required her to implement complex strategic financing and operational programs prior to its restructuring and sale to its creditors.
Prior to Interserve, Ms. White spent 13 years in senior executive roles at Sodexo SA (EuroNext: SW), a Paris-headquartered multinational diversified services company with 440,000 employees and over $20 billion in revenue, including as Chief Executive Officer of Sodexo UK & Ireland, Chief Financial Officer of Sodexo North America, an $8 billion subsidiary, and finally as Executive Board member and Global Chief Executive Officer of Healthcare and Government, two global businesses with a combined 100,000 employees and over $7 billion in revenue. While at Sodexo, she served on its global body that promoted the development of women across the company and was inducted into the industry’s Women 1st Top 100 Club, which highlights the female role models and leaders who have achieved success at the highest levels.
Prior to Sodexo, Ms. White served for 3 years as a Director at PWC Consulting, advising a range of industries, including pharmaceuticals, on integration, financial performance improvement and post-merger integration, and for 13 years in various financial and strategic roles at AstraZeneca (LSE: AZN), a UK-headquartered multinational pharmaceutical and biotechnology company. She began her career as a senior tax advisor at Arthur Andersen & Co. Ms. White received her master’s degree in Economics from Cambridge University, Cambridge UK.